The addition of luminol plus a catalyst such as peroxidase or a heme prosthetic group to a solution containing a small quantity of lipid hydroperoxides results in a flash of chemiluminescence, the intensity of which is a function of the hydroperoxide concentrations. Various protocols for lipid hydro
Chemiluminescent assay of co-factors
β Scribed by Tsuji, Akio ;Maeda, Masako ;Arakawa, Hidetoshi
- Publisher
- John Wiley and Sons
- Year
- 1989
- Weight
- 486 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0884-3996
No coin nor oath required. For personal study only.
β¦ Synopsis
Bioluminescent methods are widely used for the assay of the co-factors, NADH and ATP. Although the bioluminescent method is highly sensitive, the enzymes used are unstable and expensive. Therefore a chemiluminescent method would be valuable in clinical routine assay.
We have developed a chemiluminescent method for the assay of NADH using the I-methoxy-5-methylphenazinium methyl sulphate (1-MPMS)/isoluminol(lL)/microperoxidase(m-POD) system.
In order t o increase the sensitivity of this method, enzymatic cycling system was coupled to the chemiluminescent assay of NADH.
Alcohol dehydrogenase and malate dehydrogenase were used as the cycling enzyme. The standard curve was obtained in the range from 3 x to 5 x 10-12mol/assay. The detection limit of NADH was 30fmol/assay which was comparable to that of the bioluminescent method using bacterial luciferase.
Two chemiluminescent methods for the assay of ATP have been developed. Method 1 is the system using hexokinaseIG6PDH and 1-PMS/IL/m-POD, and method 2 is the system based on the enzymatic cycling reaction of ATP using hexokinasdpyruvate kinase. Method 2 is 1000/fold more sensitive than the method 1. The detection limit of ATP was 10fmoVassay.
π SIMILAR VOLUMES
Chemiluminescent assays have been used to quantify phagocytic activity since 1972. In recent years these assays have been adapted t o the 96-well microplate format as new luminometers have been developed. In this report w e describe the optimization of a lucigenin enhanced phagocyte chemiluminescent
Erythropoietin (EPO) is a polypeptide hormone produced by the kidney that regulates erythropoiesis by controlling the proliferation and differentiation of erythroid progenitors in bone marrow. Assays for EPO are used to monitor dosage and response to human recombinant erythropoietin also may have di
C-peptide is secreted in equimolar concentrations with insulin, and is often measured to assess pancreatic Ξ²-cell function. C-peptide analysis is most often performed by radioimmunoassay (RIA) which has several disadvantages. We evaluated an automated, chemiluminescent immunoassay for C-peptide in t